Patents by Inventor Sebastian Kaerger

Sebastian Kaerger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10314784
    Abstract: A process for preparing dry powder formulations of a glycopyrronium salt for inhalation that have good stability. The process involves (a) micronising a glycopyrronium salt together with an anti-adherent agent, and (b) admixing carrier particles to form the dry powder formulation.
    Type: Grant
    Filed: December 7, 2015
    Date of Patent: June 11, 2019
    Assignee: Novartis AG
    Inventors: Barbara Haeberlin, Frank Stowasser, Wolfgang Wirth, Anton Baumberger, Stephan Abel, Sebastian Kaerger, Thomas Kieckbusch
  • Publication number: 20170143632
    Abstract: A process for the production of particles comprises the steps of formation of a solution of a desired substance in a suitable solvent; ii) generation of an aerosol from the solution of said substance; iii) collection of the aerosol droplets in a vessel containing a non-solvent of said substance; and iv) the application of ultrasound to the droplets dispersed in the non-solvent to effect crystallisation of said substance. The particles produced find application in for example pharmaceutical and agrochemical formulations, especially in inhalation formulations.
    Type: Application
    Filed: October 23, 2016
    Publication date: May 25, 2017
    Inventors: Robert PRICE, Joerg Sebastian KAERGER
  • Publication number: 20160081934
    Abstract: A process for preparing dry powder formulations of a glycopyrronium salt for inhalation that have good stability. The process involves (a) micronising a glycopyrronium salt together with an anti-adherent agent, and (b) admixing carrier particles to form the dry powder formulation.
    Type: Application
    Filed: December 7, 2015
    Publication date: March 24, 2016
    Applicant: Novartis AG
    Inventors: Barbara Haeberlin, Frank Stowasser, Wolfgang Wirth, Anton Baumberger, Stephen Abel, Sebastian Kaerger, Thomas Kieckbusch
  • Publication number: 20150224194
    Abstract: A process for preparing dry powder formulations of a glycopyrronium salt for inhalation that have good stability. The process involves (a) micronising a glycopyrronium salt together with an anti-adherent agent, and (b) admixing carrier particles to form the dry powder formulation.
    Type: Application
    Filed: April 21, 2015
    Publication date: August 13, 2015
    Applicant: Novartis AG
    Inventors: Barbara Haeberlin, Frank Stowasser, Wolfgang Wirth, Anton Baumberger, Stephan Abel, Sebastian Kaerger, Thomas Kieckbusch
  • Publication number: 20120065174
    Abstract: A process for preparing dry powder formulations of a glycopyrronium salt for inhalation that have good stability. The process involves (a) micronising a glycopyrronium salt together with an anti-adherent agent, and (b) admixing carrier particles to form the dry powder formulation.
    Type: Application
    Filed: October 12, 2011
    Publication date: March 15, 2012
    Inventors: Barbara Haeberlin, Frank Stowasser, Wolfgang Wirth, Anton Baumberger, Stephan Abel, Sebastian Kaerger, Thomas Kieckbusch
  • Publication number: 20090209502
    Abstract: A process for preparing dry powder formulations of a glycopyrronium salt for inhalation that have good stability. The process involves (a) micronising a glycopyrronium salt together with an anti-adherent agent, and (b) admixing carrier particles to form the dry powder formulation.
    Type: Application
    Filed: June 28, 2007
    Publication date: August 20, 2009
    Inventors: Barbara Haeberlin, Frank Stowasser, Wolfgang Wirth, Anton Baumberger, Stephan Abel, Sebastian Kaerger, Thomas Kieckbusch